ASA
IOVA icon

Axxion S.A.’s Iovance Biotherapeutics IOVA Stock Holding History

Axxion S.A.’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Buy
+100,000
New +$380K 0.03% 246

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Axxion S.A.'s IOVA Position: Q2 2026 in Review

Axxion S.A. opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 100,000 shares worth $416K. The stake represents 0.03% of the portfolio and ranks #246 among its holdings.

264 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Axxion S.A. held 100,000 shares of Iovance Biotherapeutics worth $416K as of Q2 2026.
  • Iovance Biotherapeutics was a new Axxion S.A. position in Q2 2026.
  • Iovance Biotherapeutics made up 0.03% of Axxion S.A.'s portfolio in Q2 2026, its #246 holding.
  • 264 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Axxion S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.